StonvexLoading…
StonvexStonvexStonvexCore line items from PFSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.11M | $26.87M | $13.40M | $12.39M |
Operating Income | $551.42M | $401.03M | $183.63M | $665.25M |
Net Income | $501.08M | $311.42M | $144.66M | $475.51M |
EPS (Diluted) | $9.30 | $5.84 | $2.74 | $8.50 |
Total Assets | $29.39B | $26.09B | $18.84B | $16.82B |
Total Liabilities | $25.08B | $22.26B | $15.31B | $13.35B |
Cash & Equivalents | $301.68M | $238.48M | $938.37M | $1.33B |
Free Cash Flow OCF − CapEx | $-1.66B | $-4.53B | $-1.58B | $6.03B |
Shares Outstanding | 52.06M | 51.38M | 50.18M | 55.95M |